Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001816829-22-000006
Filing Date
2022-07-15
Accepted
2022-07-15 09:38:47
Documents
1
Effectiveness Date
2022-07-15
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7942
  Complete submission text file 0001816829-22-000006.txt   9182
Mailing Address C/O HIGHVISTA STRATEGIES LLC 200 CLARENDON STREET, 50TH FLOOR BOSTON MA 02116
Business Address C/O HIGHVISTA STRATEGIES LLC 200 CLARENDON STREET, 50TH FLOOR BOSTON MA 02116 (617) 406-6500
HighVista Biotechnology Specialist Fund Ltd. (Filer) CIK: 0001871686 (see all company filings)

EIN.: 981594338 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-406351 | Film No.: 221084499